Journal of Cell Science & Therapy : Citations & Metrics Report
Articles published in Journal of Cell Science & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Cell Science & Therapy has got h-index 15, which means every article in Journal of Cell Science & Therapy has got 15 average citations.
Following are the list of articles that have cited the articles published in Journal of Cell Science & Therapy.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Year wise published articles |
55 | 22 | 4 | 8 | 20 | 27 |
Year wise citations received |
117 | 111 | 110 | 120 | 126 | 103 |
| Journal total citations count | 921 |
| Journal impact factor | 8.67 |
| Journal 5 years impact factor | 6.84 |
| Journal cite score | 8.35 |
| Journal h-index | 15 |
| Journal h-index since 2017 | 12 |
Important citations
The impact of the extent of thyroid resection complemented by radioiodine management on disease free status and discharge rates among differentiated thyroid cancer patients: a retrospective analysis. |
|
Pyramidal lobe decreases endogenous tsh stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer. |
|
Pituitary, gonadal, thyroid hormones and endocrine disruptors in pre and postmenopausal nigerian women with er-, pr- and her-2-positive and negative breast cancers. |
|
Interleukin-27 protects cardiomyocyte-like h9c2 cells against metabolic syndrome: role of stat3 signaling |
|
Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis. |
|
Targeting the ecirp/trem-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis. |
|
Fgf13 is a novel regulator of nf-?b and potentiates pathological cardiac hypertrophy. |
|
impact of sglt2 inhibitors on heart failure: from pathophysiology to clinical effects. |
|
Comparative effects of parent and heated cinnamaldehyde on the function of human ipsc-derived cardiac myocytes |
|
Proinflammatory cytokines and ageing of the cardiovascular-renal system. |
|
Management of inflammation in cardiovascular diseases. |
|
Post-ttm rebound pyrexia after ischemia-reperfusion injury results in sterile inflammation and apoptosis in cardiomyocytes. |
|
Phosphorylation of hsp20 promotes fibrotic remodeling and heart failure |
|
pathophysiology of cancer therapy-provoked atrial fibrillation |
|
Fibrosis in chronic kidney disease: pathogenesis and consequences |
|
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients. |
|
Absent in melanoma 2 (aim2) limits pro-inflammatory cytokine transcription in cardiomyocytes by inhibiting stat1 phosphorylation. |
|
Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine |
|
Inhibition of sars-cov-2 infection in human cardiomyocytes by targeting the sigma-1 receptor disrupts cytoskeleton architecture and contractility |
|
The role of bone morphogenetic protein 7 (bmp-7) in inflammation in heart diseases |
|